Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 21001-21050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
PHASE1Recruiting
20 participants
Started: Jul 24, 2024 · Completed: Aug 31, 2026
5 conditions2 sponsors1 location
NCT06538337
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
NARecruiting
60 participants
Started: Jul 24, 2024 · Completed: Jul 26, 2032
2 conditions1 sponsor1 location
NCT06821048
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
PHASE1Recruiting
18 participants
Started: Jul 24, 2024 · Completed: Dec 1, 2027
4 conditions2 sponsors1 location
NCT07112781
Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer
NARecruiting
30 participants
Started: Jul 24, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06321965
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
NARecruiting
60 participants
Started: Jul 24, 2024 · Completed: Jan 24, 2029
1 condition1 sponsor8 locations
NCT06931002
A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis
NARecruiting
54 participants
Started: Jul 24, 2024 · Completed: Oct 30, 2027
5 conditions2 sponsors1 location
NCT06454578
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
PHASE2Recruiting
30 participants
Started: Jul 24, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06526338
Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
PHASE2Recruiting
126 participants
Started: Jul 24, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06587724
Investigation of the Validity, Reliability, and Responsiveness of the BETY-BQ in Myositis
N/ARecruiting
100 participants
Started: Jul 24, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06481618
Impact of Stress on Management of BAVU Ventilation (Self-filling Bag With One-way Valve) by Healthcare Professionals.
N/ARecruiting
90 participants
Started: Jul 24, 2024 · Completed: Oct 31, 2024
3 conditions1 sponsor1 location
NCT06167096
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
NARecruiting
100 participants
Started: Jul 24, 2024 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT05896839
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
PHASE1/PHASE2Recruiting
16 participants
Started: Jul 24, 2024 · Completed: Jan 31, 2027
13 conditions1 sponsor25 locations
NCT06096597
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
PHASE2/PHASE3Recruiting
100 participants
Started: Jul 24, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06013878
Biomechanical Validation of the CATT
N/ARecruiting
160 participants
Started: Jul 24, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT07093970
A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
343 participants
Started: Jul 24, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT06529549
Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment
N/ARecruiting
30 participants
Started: Jul 24, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06209359
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
PHASE1Recruiting
50 participants
Started: Jul 24, 2024 · Completed: Mar 1, 2028
2 conditions2 sponsors1 location
NCT06442436
A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
PHASE1Recruiting
16 participants
Started: Jul 24, 2024 · Completed: Dec 12, 2025
1 condition1 sponsor3 locations
NCT06972537
A Study on the Infusion Regimen of Piperacillin-Tazobactam in Patients Aged 65 and Older With Pneumonia
NARecruiting
42 participants
Started: Jul 24, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06787911
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
PHASE2Recruiting
14 participants
Started: Jul 24, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06481969
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
NARecruiting
260 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06764836
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
PHASE1Recruiting
108 participants
Started: Jul 23, 2024 · Completed: Jan 27, 2026
2 conditions1 sponsor1 location
NCT06169215
Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
PHASE2Recruiting
70 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor27 locations
NCT06501846
Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.
NARecruiting
92 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2027
3 conditions1 sponsor1 location
NCT06516848
High-intensity Inspiratory Muscle Training in Patients With Asthma
NARecruiting
34 participants
Started: Jul 23, 2024 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06239753
The Impact of Dynamic Neuromuscular Stabilization on Pregnancy
NARecruiting
144 participants
Started: Jul 23, 2024 · Completed: Jul 2, 2025
2 conditions1 sponsor1 location
NCT06578559
Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC
PHASE2Recruiting
16 participants
Started: Jul 23, 2024 · Completed: Apr 1, 2027
1 condition3 sponsors13 locations
NCT06113016
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
PHASE2Recruiting
164 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2028
4 conditions4 sponsors6 locations
NCT06137807
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NARecruiting
50 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2029
2 conditions3 sponsors36 locations
NCT06488755
SIM0718 Treatment of Asthma Clinical Study
PHASE3Recruiting
418 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06351150
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
PHASE3Recruiting
214 participants
Started: Jul 23, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor42 locations
NCT06526234
Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
N/ARecruiting
500 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2025
1 condition1 sponsor1 location
NCT06551831
End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
N/ARecruiting
30 participants
Started: Jul 23, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06551090
Prediction of Anxiety and Memory State
N/ARecruiting
40 participants
Started: Jul 23, 2024 · Completed: Dec 1, 2026
3 conditions4 sponsors1 location
NCT06544915
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
NARecruiting
60 participants
Started: Jul 23, 2024 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT06112860
OTC Hearing Aid and MCI
NARecruiting
50 participants
Started: Jul 23, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor3 locations
NCT06216483
Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium
NARecruiting
60 participants
Started: Jul 23, 2024 · Completed: Feb 11, 2026
1 condition2 sponsors1 location
NCT05427058
Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
NARecruiting
36 participants
Started: Jul 23, 2024 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT06550245
Babies' Brain Responses to Strangers
N/ARecruiting
100 participants
Started: Jul 23, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06260033
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
PHASE2Recruiting
18 participants
Started: Jul 23, 2024 · Completed: Oct 29, 2026
3 conditions2 sponsors2 locations
NCT06427941
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
140 participants
Started: Jul 23, 2024 · Completed: Oct 30, 2026
6 conditions1 sponsor15 locations
NCT06098508
Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients
NARecruiting
10 participants
Started: Jul 23, 2024 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT06349889
Adebrelimab and Chemoradiotherapy in High-risk LANPC
PHASE2Recruiting
50 participants
Started: Jul 23, 2024 · Completed: May 1, 2028
2 conditions4 sponsors4 locations
NCT06284876
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
PHASE3Recruiting
416 participants
Started: Jul 23, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor2 locations
NCT06469801
ECMO ABI Detection With Hyperfine
NARecruiting
30 participants
Started: Jul 23, 2024 · Completed: Jul 1, 2026
4 conditions1 sponsor1 location
NCT06755775
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
N/ARecruiting
150 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2029
1 condition1 sponsor1 location
NCT06125197
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
PHASE1Recruiting
22 participants
Started: Jul 23, 2024 · Completed: May 30, 2026
1 condition2 sponsors2 locations
NCT07197034
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
PHASE3Recruiting
90 participants
Started: Jul 23, 2024 · Completed: Apr 30, 2027
3 conditions1 sponsor36 locations
NCT06530966
Phase I Study of ICP-332 in Healthy Subjects
PHASE1Recruiting
24 participants
Started: Jul 23, 2024 · Completed: Dec 25, 2024
1 condition1 sponsor1 location
NCT06512116
A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.
PHASE1Recruiting
196 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location